Home > Income Statement > BLISS GVS PHARMA

BLISS GVS PHARMA
Consolidated Net Profit

    Back to Income Statement
BLISS GVS PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

BLISS GVS PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹75 Cr₹71 Cr₹15 Cr₹68 Cr₹97 Cr

What is the latest Consolidated Net Profit of BLISS GVS PHARMA ?

The latest Consolidated Net Profit ratio of BLISS GVS PHARMA is ₹75 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹75 Cr
Mar2024₹71 Cr
Mar2023₹15 Cr
Mar2022₹68 Cr
Mar2021₹97 Cr

How is Consolidated Net Profit of BLISS GVS PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹75 Cr
6.48
Mar2024 ₹71 Cr
371.14
Mar2023 ₹15 Cr
-78.04
Mar2022 ₹68 Cr
-29.58
Mar2021 ₹97 Cr -

Compare Consolidated Net Profit of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹2,736.5 Cr 9.1% 26.5% 101.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

9.1%

26.5%

101.5%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses